Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome

About 10–20% of breast/ovarian (BC/OC) cancer patients undergoing germline BRCA1/2 genetic testing have been shown to harbor Variants of Uncertain Significance (VUSs). Since little is known about the prevalence of germline BRCA1/2 VUS in Southern Italy, our study aimed at describing the spectrum of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fanale, Daniele, Fiorino, Alessia, Incorvaia, Lorena, Dimino, Alessandra, Filorizzo, Clarissa, Bono, Marco, Cancelliere, Daniela, Calò, Valentina, Brando, Chiara, Corsini, Lidia Rita, Sciacchitano, Roberta, Magrin, Luigi, Pivetti, Alessia, Pedone, Erika, Madonia, Giorgio, Cucinella, Alessandra, Badalamenti, Giuseppe, Russo, Antonio, Bazan, Viviana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226162/
https://www.ncbi.nlm.nih.gov/pubmed/34178674
http://dx.doi.org/10.3389/fonc.2021.682445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226162/
https://www.ncbi.nlm.nih.gov/pubmed/34178674
http://dx.doi.org/10.3389/fonc.2021.682445

Ejemplares similares